GJB2 and hearing loss disorder: STRC pathogenic variants account for 4.08% of GJB2-negative congenital hearing loss cases and represent 14.36% of mild-to-moderate hearing loss patients, with biallelic deletions comprising approximately 70% of all STRC pathogenic alleles [15].